BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 37020591)

  • 1. Autophagy and its therapeutic potential in diabetic nephropathy.
    Han YP; Liu LJ; Yan JL; Chen MY; Meng XF; Zhou XR; Qian LB
    Front Endocrinol (Lausanne); 2023; 14():1139444. PubMed ID: 37020591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference in the nutrient-sensing and inflammatory signaling pathways by renal autophagy activation in mice with late stage diabetic nephropathy.
    Li D; Yuan S; Deng Y
    Int Urol Nephrol; 2024 Jan; 56(1):303-311. PubMed ID: 37355515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy in diabetic nephropathy.
    Ding Y; Choi ME
    J Endocrinol; 2015 Jan; 224(1):R15-30. PubMed ID: 25349246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
    Packer M
    J Am Soc Nephrol; 2020 May; 31(5):907-919. PubMed ID: 32276962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of autophagy in the pathogenesis of diabetic nephropathy.
    Yamahara K; Yasuda M; Kume S; Koya D; Maegawa H; Uzu T
    J Diabetes Res; 2013; 2013():193757. PubMed ID: 24455746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.
    Yang D; Livingston MJ; Liu Z; Dong G; Zhang M; Chen JK; Dong Z
    Cell Mol Life Sci; 2018 Feb; 75(4):669-688. PubMed ID: 28871310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophagy: A Potential Therapeutic Target for Diabetic Nephropathy.
    Yang M; Song P; Zhao L; Wang X
    Curr Med Chem; 2023; 30(16):1875-1886. PubMed ID: 35894456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research Progress in Stress-Induced Senescence of Renal Tubular Cells in Diabetic Nephropathy].
    Yi X; He Y; Chen K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1085-1090. PubMed ID: 38162078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors.
    Packer M
    Am J Nephrol; 2020; 51(4):289-293. PubMed ID: 32126558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy.
    Liu WJ; Shen TT; Chen RH; Wu HL; Wang YJ; Deng JK; Chen QH; Pan Q; Huang Fu CM; Tao JL; Liang D; Liu HF
    J Biol Chem; 2015 Aug; 290(33):20499-510. PubMed ID: 26100632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy.
    Kume S; Koya D; Uzu T; Maegawa H
    Biomed Res Int; 2014; 2014():315494. PubMed ID: 25126552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis.
    Xu J; Liu LQ; Xu LL; Xing Y; Ye S
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):599-608. PubMed ID: 31821581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitophagy: A Novel Therapeutic Target for Treating DN.
    Yang M; Li C; Yang S; Xiao Y; Chen W; Gao P; Jiang N; Xiong S; Wei L; Zhang Q; Yang J; Zeng L; Sun L
    Curr Med Chem; 2021; 28(14):2717-2728. PubMed ID: 33023427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.
    Kitada M; Ogura Y; Monno I; Koya D
    Curr Diab Rep; 2017 Jul; 17(7):53. PubMed ID: 28593583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway.
    Tian H; Zheng X; Wang H
    Int Urol Nephrol; 2023 Feb; 55(2):423-436. PubMed ID: 35960477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy: emerging therapeutic target for diabetic nephropathy.
    Kume S; Yamahara K; Yasuda M; Maegawa H; Koya D
    Semin Nephrol; 2014 Jan; 34(1):9-16. PubMed ID: 24485025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressing STAMP2 attenuates diabetic renal injuries via upregulating autophagy in diabetic rats.
    Song FQ; Song M; Ma WX; Gao Z; Ti Y; Zhang X; Hu BA; Zhong M; Zhang W; Yu Y
    Biochem Biophys Res Commun; 2021 Nov; 579():47-53. PubMed ID: 34583195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy.
    Yang C; Chen XC; Li ZH; Wu HL; Jing KP; Huang XR; Ye L; Wei B; Lan HY; Liu HF
    Autophagy; 2021 Sep; 17(9):2325-2344. PubMed ID: 33043774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway.
    Li A; Yi B; Han H; Yang S; Hu Z; Zheng L; Wang J; Liao Q; Zhang H
    Autophagy; 2022 Apr; 18(4):877-890. PubMed ID: 34432556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.